Hemoglobin is a globular protein found in red blood cells that is responsible for transporting oxygen from the lungs to tissues and facilitating carbon dioxide removal. Beyond its central role in oxygen transport, hemoglobin levels serve as an important biomarker for evaluating overall hematologic health. Abnormal hemoglobin concentrations can indicate conditions such as anemia, hemoglobinopathies, blood loss, or chronic diseases affecting red blood cell production and function. Monitoring hemoglobin is therefore critical for both basic research and clinical diagnostics.
Hemoglobin ELISA (enzyme-linked immunosorbent assay) provides a sensitive and specific method to quantify hemoglobin in blood, plasma, or other biological samples. In research settings, hemoglobin ELISAs are used to study erythropoiesis, red blood cell turnover, and hemolytic processes. They also help in evaluating the impact of experimental treatments, toxins, or genetic modifications on hemoglobin levels and red blood cell function, enabling a better understanding of disease mechanisms or therapeutic effects.
Clinically, hemoglobin ELISA can be applied to assess anemia, monitor treatment responses, or detect hemolysis and other hematologic disorders. It is particularly useful in situations where precise quantification of hemoglobin is needed beyond standard hematology analyzers, such as in research trials, neonatology, or studies of chronic diseases affecting red blood cells. By providing a reliable measure of hemoglobin concentration, ELISA-based assays support both diagnosis and ongoing patient management.
This product is manufactured in USA by Eagle Biosciences.
| Size | 1 x 96 Well |
| Sensitivity | 1.103 ng/mL |
| Dynamic Range | 6.25 ng/mL – 200 ng/mL |
| Incubation Time | 50 minutes |
| Sample Type | Serum, plasma |
| Storage | 2-8°C |
| Alternative Names | Hgb, Hb, oxyhemoglobin, carboxyhemoglobin, and deoxyhemoglobin. |